Montelukast Doc Generici

Montelukast, the active ingredient in Montelukast Doc Generici, is a leukotriene receptor antagonist presented as a tablet for oral use. It treats asthma as maintenance therapy and allergic rhinitis in adults and children.

GNH USA supplies Montelukast Doc Generici as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Montelukast acts on the leukotriene pathway to manage chronic respiratory and allergic conditions. - Asthma: improves long‑term control and reduces exacerbations in patients with persistent asthma. - Allergic rhinitis: relieves nasal congestion, sneezing and itching associated with seasonal or perennial allergies. - Exercise‑induced bronchospasm: prevents airway narrowing during physical activity in susceptible individuals.

Montelukast is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate pain often reported. - Abdominal pain: discomfort or cramps in the stomach area. - Nausea: feeling of queasiness without vomiting. - Dizziness: transient light‑headedness or unsteadiness. - Fatigue: unusual tiredness or lack of energy. - Cough: occasional irritation of the throat.

Serious or Rare Side Effects: - Allergic reactions: rash, angioedema, or anaphylaxis. - Neuropsychiatric events: mood changes, depression, or suicidal thoughts. - Hepatic enzyme elevation: abnormal liver function tests. - Blood dyscrasias: neutropenia or eosinophilia. - Severe bronchospasm: paradoxical worsening of breathing. - Stevens‑Johnson syndrome: rare severe skin reaction.

Before prescribing Montelukast, clinicians should consider several safety aspects. - Assess asthma control: ensure baseline therapy is optimized. - Monitor neuropsychiatric symptoms: watch for mood changes or depression. - Use cautiously in hepatic impairment: adjust if liver function is compromised. - Review concomitant medications: avoid drugs that significantly alter metabolism. - Store below 25°C: keep in the original pack, protect from moisture.

Montelukast may interact with other medicines, requiring attention to the interaction level.

Major Interactions (Avoid): - Phenobarbital: induces metabolism, reducing efficacy. - Rifampin: strong enzyme inducer that lowers plasma levels. - Ketoconazole: inhibits metabolism, potentially increasing exposure.

Moderate Interactions (Monitor Closely): - Warfarin: possible alteration of anticoagulant effect. - Oral contraceptives: may reduce hormonal efficacy. - Other leukotriene modifiers: additive effects on leukotriene pathways. - Fluconazole: moderate inhibition of metabolism requiring observation.